<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR78">
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Han</surname>
    <given-names>SJ</given-names>
   </name>
   <name>
    <surname>Kim</surname>
    <given-names>HS</given-names>
   </name>
   <name>
    <surname>Kim</surname>
    <given-names>KI</given-names>
   </name>
   <name>
    <surname>Whang</surname>
    <given-names>SM</given-names>
   </name>
   <name>
    <surname>Hong</surname>
    <given-names>KS</given-names>
   </name>
   <name>
    <surname>Lee</surname>
    <given-names>WK</given-names>
   </name>
   <name>
    <surname>Lee</surname>
    <given-names>SH</given-names>
   </name>
  </person-group>
  <article-title>Use of Nafamostat Mesilate as an anticoagulant during extracorporeal membrane oxygenation</article-title>
  <source>J Korean Med Sci</source>
  <year>2011</year>
  <volume>26</volume>
  <fpage>945</fpage>
  <lpage>950</lpage>
  <pub-id pub-id-type="doi">10.3346/jkms.2011.26.7.945</pub-id>
  <?supplied-pmid 21738350?>
  <pub-id pub-id-type="pmid">21738350</pub-id>
 </element-citation>
</ref>
